The clinical or research-based use of the four specific transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM)—or their chemical or modified mRNA analogs, to induce a state of partial or full cellular reprogramming. The application is studied in longevity science for its potential to reverse cellular aging, regenerate damaged tissues, and restore youthful gene expression patterns. This is a highly experimental, frontier area of regenerative medicine.
Origin
This term is directly derived from the groundbreaking work of Professor Shinya Yamanaka, who first demonstrated that these four factors could revert adult somatic cells into induced pluripotent stem cells (iPSCs), a discovery that earned him the Nobel Prize. The subsequent “application” refers to attempts to translate this laboratory technique into therapeutic strategies for anti-aging.
Mechanism
The Yamanaka factors function by binding to specific regulatory regions of the genome, initiating a cascade of gene expression changes that fundamentally restructure the cell’s epigenetic landscape. This process dismantles the established adult cell identity and drives the cell back toward a pluripotent state. Therapeutic application aims for partial reprogramming, which is hypothesized to reset the epigenetic clock and clear cellular damage without causing the uncontrolled proliferation associated with full pluripotency.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.